Participated · Equity · May 2026

Rep AI provides a unified, agentic AI platform for ecommerce that spans behavioral intent detection on arrival through personalized sales guidance, conversion optimization, and post-purchase support. The platform is built on proprietary behavioral AI and large language models, and it ingests each brand’s voice and product knowledge to deliver shared shopper intelligence across marketing, CX, and sales teams. Rep AI counts customers including Proof Wallets, VIBAe, K2, Unclaimed Baggage, Satya Jewelry, HigherDOSE, OLLY, Cloth & Paper, Bikes Online, and NutraBio. The company plans to use its latest $6.2 million follow-on funding to accelerate product innovation, expand market reach, and support enterprise growth. Rep AI is backed by Silicon Road Ventures, Osage Venture Partners, Flashpoint Venture Capital, and Zendesk, and it previously raised an $8.2 million Series A in August 2024.

Participated · Seed · Apr 2026

Iridius offers a platform composed of a knowledge engine that breaks regulations down rule-by-rule for real-time queries by AI agents and a solution factory that helps customers design, build, and connect compliant AI workflows to existing enterprise systems. The company's initial focus is life sciences and pharmaceutical customers, where it targets detailed compliance, validation, and audit requirements. Iridius was founded in 2024 by Mike Kropp and Alistair Lowe-Norris and has a leadership team with veterans from Microsoft, AWS, OpenAI, and Amazon. The startup has assembled an advisory bench of former CIOs from major pharma and medtech companies and added Clark Golestani, former Merck CIO, to its board. Iridius has not yet commercially launched its product but has a signed co-development agreement with a pharmaceutical customer and is in active discussions with others. Following its $8.6M seed raise, the company is expanding hiring, particularly for its AI engineering team.

Led · Seed · Dec 2025

BoodleBox offers a single, secure interface that aggregates leading AI models such as GPT-5.1, Claude, Gemini, Perplexity, and LLAMA, enabling responsible, multi-user collaboration. Its proprietary token-reduction technology can lower AI operating costs and environmental impact by up to 96 % while maintaining enterprise-grade security and FERPA compliance. Launched in Q4 2024, the platform is already used at more than 1,200 higher-education institutions and over 100 workforce teams, with 80 institutions deploying BoodleBox’s AI infrastructure to serve 70,000+ faculty, staff, and students. Key features include custom bot building, AI coaching, team collaboration, and data portability that lets graduates retain their AI-assisted work. The company addresses the widening AI-skills gap by providing affordable access to tools that 66 % of employers now require, yet only 24 % of low-income students can reach. With fresh capital, BoodleBox plans to deepen its higher-ed presence, enhance product capabilities, and enter sectors such as corporate training, public sector, and specialized industries. It will also relocate its headquarters to Colorado Springs, Colorado, to capitalize on a favorable business environment and tech talent pool.

Participated · Series A · Dec 2025

Founded in 2021, Denver-based Lin Health offers a physician-led, coach-supported virtual program that retrains maladaptive pain circuits through therapies such as Pain Reprocessing Therapy, Emotional Awareness and Expression Therapy, and Cognitive Behavioral Therapy. The platform combines proprietary software, AI, and a collaborative care model to engage patients multiple times per week without adding administrative burden. Lin partners with health systems, clinics, and payers and is already accessible to more than 60 million covered Americans. Its solution targets chronic conditions including migraines, IBS, back pain, and joint pain, addressing a $635 billion annual cost burden in the U.S. healthcare system. The company emphasizes value-based outcomes, reduced provider burnout, and lower total cost of care. With fresh Series A capital, Lin plans to accelerate product innovation, scale go-to-market efforts, and deepen clinically integrated partnerships. The oversubscribed funding signals strong investor confidence in Lin’s ability to become the first-line solution for chronic pain nationwide.

Participated · Series A · Oct 2025

Returnalyze is a Boston-based technology company that offers an AI-driven platform designed to prevent and manage product returns across the retail value chain. Its real-time algorithms generate actionable insights for merchandising, e-commerce, and supply-chain teams, enabling merchants to intervene before a return occurs and to optimize post-return workflows when necessary. The system also integrates with leading commerce and logistics solutions such as Shopify and Salesforce Commerce Cloud through a growing portfolio of APIs. Returnalyze currently serves more than 40 retail brands, demonstrating early market traction and validation of its product. Looking ahead, the company plans to deepen its AI capabilities, expand integrations with additional industry platforms, and scale its engineering, data science, and customer-facing teams to meet rising enterprise demand. The recent capital injection will directly fund these initiatives and accelerate overall growth.